Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis
GiuseppeLippi, MarioPlebani
Show more
https://doi.org/10.1016/j.cca.2020.03.004
Coronavirus disease 2019 (COVID-19), a new form of respiratory and systemic disorder sustained by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now producing an outbreak of pandemic proportions, whereby nearly 90,000 people have already been infected around the world, 10-15% of whom with severe disease and over 2900 already died [1]. A severe form of pneumonia, potentially evolving towards adult respiratory distress syndrome (ARDS) and occasionally associated with multiorgan failure, are the leading complications of this respiratory virus [2].
